Search results
ET in the Classroom: Different methods of holding your mutual fund units
The Economic Times· 27 minutes agoAs many as 7.9 million new investors started investing in mutual funds over the last one year,...
Market participants seek higher STT on high-frequency F&O trade
Financial Express· 5 days agoFinancial market participants on Thursday made a slew of suggestions to the finance minister Nirmala...
Sun Pharma’s investigational weight loss drug shows promise in reducing obesity
Business Today· 4 days agoThe study enrolled 24 obese male participants who were divided into two groups: one with a fixed...
More than 20 loss making firms paid dividends in FY24
CNBC Awaaz· 21 hours agoSome of the loss-making companies that plan to pay dividends include Gujarat Alkalies and Chemicals...
Osivax concludes subject enrolment in Phase I sarbecovirus vaccine trial
Clinical Trials Arena· 14 hours agoFrench biotechnology company Osivax has finished enrolling subjects in its Phase I clinical trial of...
Here's how SEBI probes irregularities at mutual fund companies
CNBC Awaaz· 1 day agoThe Securities and Exchange Board of India (SEBI) has put in place many checks and balances to...
Ethris shares positive data with mRNA drug following new funding
Clinical Trials Arena· 9 hours agoThe German biotech company is using its Stabilised NanoParticle (SNaP) LNP platform to locally...
Auto, auto ancillary sector a good theme to play the rural recovery: Devang Mehta
The Economic Times· 6 days agoSome of the FMCG participants also came in this analyst guidance that most of these companies are...
ET Explainer: What are block and bulk deals?
The Economic Times· 6 days agoBlock and bulk deals are large transactions that are executed on the stock exchanges. While block deals happen through a special trading window on the...
Gilead's long-acting HIV drug superior to daily pill Truvada in study - ET HealthWorld | Pharma
The Economic Times· 5 days agoLondon: Gilead Sciences said on Thursday a late-stage study showed its injectable drug, lenacapavir,...